Anti-RSK6 monoclonal antibody
Pre-made anti-RSK6 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to RSK6/RPS6KA6 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T95878-Ab-1/ GM-Tg-hg-T95878-Ab-2 | Anti-Human RSK6/RPS6KA6 monoclonal antibody | Human |
GM-Tg-rg-T95878-Ab-1/ GM-Tg-rg-T95878-Ab-2 | Anti-Rat RSK6/RPS6KA6 monoclonal antibody | Rat |
GM-Tg-mg-T95878-Ab-1/ GM-Tg-mg-T95878-Ab-2 | Anti-Mouse RSK6/RPS6KA6 monoclonal antibody | Mouse |
GM-Tg-cynog-T95878-Ab-1/ GM-Tg-cynog-T95878-Ab-2 | Anti-Cynomolgus/ Rhesus macaque RSK6/RPS6KA6 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T95878-Ab-1/ GM-Tg-felg-T95878-Ab-2 | Anti-Feline RSK6/RPS6KA6 monoclonal antibody | Feline |
GM-Tg-cang-T95878-Ab-1/ GM-Tg-cang-T95878-Ab-2 | Anti-Canine RSK6/RPS6KA6 monoclonal antibody | Canine |
GM-Tg-bovg-T95878-Ab-1/ GM-Tg-bovg-T95878-Ab-2 | Anti-Bovine RSK6/RPS6KA6 monoclonal antibody | Bovine |
GM-Tg-equg-T95878-Ab-1/ GM-Tg-equg-T95878-Ab-2 | Anti-Equine RSK6/RPS6KA6 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T95878-Ab-1/ GM-Tg-hg-T95878-Ab-2; GM-Tg-rg-T95878-Ab-1/ GM-Tg-rg-T95878-Ab-2; GM-Tg-mg-T95878-Ab-1/ GM-Tg-mg-T95878-Ab-2; GM-Tg-cynog-T95878-Ab-1/ GM-Tg-cynog-T95878-Ab-2; GM-Tg-felg-T95878-Ab-1/ GM-Tg-felg-T95878-Ab-2; GM-Tg-cang-T95878-Ab-1/ GM-Tg-cang-T95878-Ab-2; GM-Tg-bovg-T95878-Ab-1/ GM-Tg-bovg-T95878-Ab-2; GM-Tg-equg-T95878-Ab-1/ GM-Tg-equg-T95878-Ab-2 |
Products Name | Anti-RSK6/RPS6KA6 monoclonal antibody |
Format | mab |
Target Name | RSK6 |
Protein Sub-location | Introcelluar Protein |
Category of antibody | Therapeutics Target antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-RSK6 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-T95878-Ag-1 | Recombinant multi-species KS6A6/ RSK6/ RPS6KA6 protein |
ORF Viral Vector | pGMLPm003591 | mouse Rps6ka6 Lentivirus plasmid |
ORF Viral Vector | vGMLPm003591 | mouse Rps6ka6 Lentivirus particle |
Target information
Target ID | GM-T95878 |
Target Name | RSK6 |
Gene ID | 27330,67071,317203,710337,491989,101094163,526227,100072397 |
Gene Symbol and Synonyms | 2610524K04Rik,p90RSK6,PP90RSK4,RGD1560817,RPS6KA6,RSK-4,RSK4,S6K-alpha-6 |
Uniprot Accession | Q9UK32 |
Uniprot Entry Name | KS6A6_HUMAN |
Protein Sub-location | Introcelluar Protein |
Category | Therapeutics Target |
Disease | N/A |
Gene Ensembl | ENSG00000072133 |
Target Classification | Kinase |
The target: RSK6, gene name: RPS6KA6, also named as PP90RSK4, RSK-4, RSK4, S6K-alpha-6, p90RSK6. This gene encodes a member of ribosomal S6 kinase family, serine-threonine protein kinases which are regulated by growth factors. The encoded protein may be distinct from other members of this family, however, as studies suggest it is not growth factor dependent and may not participate in the same signaling pathways. [provided by RefSeq, Jan 2010].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.